SAN DIEGO, CA — October 31, 2025 — Leads & Copy — Capricor Therapeutics (NASDAQ: CAPR) will release its third quarter financial results on Monday, November 10, 2025, after market close. Management will host a webcast and conference call at 4:30 p.m. ET on the same day.
Call details include toll-free access at 1-800-717-1738, international access at 1-646-307-1865, and conference ID 13683. A replay of the webcast will be available on the company’s website.
Capricor Therapeutics is focused on developing cell and exosome-based therapeutics for rare diseases. Its lead product candidate, Deramiocel, is in late-stage clinical development for Duchenne muscular dystrophy (DMD). Capricor is also using its StealthX™ platform in preclinical development for vaccinology and targeted delivery of therapeutics.
Capricor Media Contact:
Raquel Cona
KCSA Strategic Communications
rcona@kcsa.com
212.896.1204
Capricor Company Contact:
AJ Bergmann, Chief Financial Officer
abergmann@capricor.com
858.727.1755
Source: Capricor Therapeutics
